M G 31
Pill imprint M G 31 has been identified as Glipizide and metformin HCl 2.5 mg / 250 mg.
Glipizide/metformin is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy.
Glipizide/metformin 2.5 mg / 250 mg is not subject to the Controlled Substances Act.
See also related documents.
Glipizide and metformin HCl Images
- Imprint:
-
M
G 31 - Strength:
- 2.5 mg / 250 mg
- Color:
- White
- Size:
- 10.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- croscarmellose sodium
hypromellose
magnesium stearate
microcrystalline cellulose
polydextrose
polyethylene glycol
povidone
sodium lauryl sulfate
titanium dioxide
triacetin
- Drug Class:
- Antidiabetic combinations
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00378-3131
Advertisement
More Glipizide and Metformin HCl resources
- Glipizide/Metformin (Wolters Kluwer)
- glipizide and metformin (Cerner Multum)
- glipizide and metformin (Micromedex) - Includes Dosage Information
- Glipizide and Metformin (FDA)
- Glipizide/Metformin Hydrochloride (Wolters Kluwer)
Search Again
